[(2R,3R,4S,5R,6R)-4-[(2R,3R,4S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[(2R,3R,4S,5R)-2-[(1S,2S,3'R,4R,4'R,6R,7R,8R,9R,12R,13R,16R)-7-[[(2S,3R,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3',16-dihydroxy-9,13-dimethyl-5'-methylidene-4'-[(2R,3R,4S,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14-yl]oxy-5-hydroxy-4-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-5-hydroxy-2-methyloxan-3-yl] acetate

Details

Top
Internal ID fc112af7-0b92-4c1a-a65a-cfc1dbc00232
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name [(2R,3R,4S,5R,6R)-4-[(2R,3R,4S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[(2R,3R,4S,5R)-2-[(1S,2S,3'R,4R,4'R,6R,7R,8R,9R,12R,13R,16R)-7-[[(2S,3R,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3',16-dihydroxy-9,13-dimethyl-5'-methylidene-4'-[(2R,3R,4S,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14-yl]oxy-5-hydroxy-4-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-5-hydroxy-2-methyloxan-3-yl] acetate
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C3(C(C4C(O3)CC5C4(CCC6C5CC=C7C6(C(CC(C7)O)OC8C(C(C(CO8)O)OC9C(C(C(CO9)O)O)O)OC1C(C(C(C(O1)C)OC(=O)C)OC1C(C(CO1)(CO)O)O)O)C)C)COC1C(C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)OCC2=C)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]2[C@H]([C@]3([C@H]([C@H]4[C@H](O3)C[C@@H]5[C@]4(CC[C@@H]6[C@H]5CC=C7[C@@]6(C(C[C@@H](C7)O)O[C@@H]8[C@@H]([C@H]([C@@H](CO8)O)O[C@@H]9[C@@H]([C@H]([C@H](CO9)O)O)O)O[C@@H]1[C@@H]([C@@H]([C@@H]([C@H](O1)C)OC(=O)C)O[C@@H]1[C@@H]([C@@](CO1)(CO)O)O)O)C)C)CO[C@@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)CO)O)O)O[C@@H]1[C@@H]([C@H]([C@H]([C@@H](O1)CO)O)O)O)OCC2=C)O)O)O)O
InChI InChI=1S/C68H106O38/c1-22-16-94-68(56(87)50(22)101-59-47(84)43(80)39(76)23(2)95-59)31(17-90-62-54(45(82)42(79)36(15-70)99-62)104-60-48(85)44(81)41(78)35(14-69)98-60)38-34(106-68)13-30-28-8-7-26-11-27(73)12-37(66(26,6)29(28)9-10-65(30,38)5)100-63-55(52(33(75)19-92-63)102-58-46(83)40(77)32(74)18-91-58)105-61-49(86)53(51(24(3)96-61)97-25(4)72)103-64-57(88)67(89,20-71)21-93-64/h7,23-24,27-64,69-71,73-89H,1,8-21H2,2-6H3/t23-,24+,27+,28+,29+,30-,31-,32-,33+,34+,35-,36-,37?,38-,39+,40-,41-,42+,43-,44-,45-,46+,47+,48+,49+,50+,51+,52-,53-,54+,55+,56+,57-,58+,59+,60+,61+,62-,63+,64+,65+,66-,67-,68+/m0/s1
InChI Key GEVWTYAARPHCGN-NVCLYLIMSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C68H106O38
Molecular Weight 1531.50 g/mol
Exact Mass 1530.6362089 g/mol
Topological Polar Surface Area (TPSA) 579.00 Ų
XlogP -8.30
Atomic LogP (AlogP) -9.17
H-Bond Acceptor 38
H-Bond Donor 20
Rotatable Bonds 19

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2R,3R,4S,5R,6R)-4-[(2R,3R,4S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[(2R,3R,4S,5R)-2-[(1S,2S,3'R,4R,4'R,6R,7R,8R,9R,12R,13R,16R)-7-[[(2S,3R,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3',16-dihydroxy-9,13-dimethyl-5'-methylidene-4'-[(2R,3R,4S,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14-yl]oxy-5-hydroxy-4-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-5-hydroxy-2-methyloxan-3-yl] acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8103 81.03%
Caco-2 - 0.8657 86.57%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.8000 80.00%
Subcellular localzation Mitochondria 0.7885 78.85%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8180 81.80%
OATP1B3 inhibitior + 0.8568 85.68%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior + 0.9512 95.12%
P-glycoprotein inhibitior + 0.7435 74.35%
P-glycoprotein substrate + 0.7917 79.17%
CYP3A4 substrate + 0.7680 76.80%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8822 88.22%
CYP3A4 inhibition - 0.8845 88.45%
CYP2C9 inhibition - 0.9065 90.65%
CYP2C19 inhibition - 0.9142 91.42%
CYP2D6 inhibition - 0.9374 93.74%
CYP1A2 inhibition - 0.9048 90.48%
CYP2C8 inhibition + 0.8430 84.30%
CYP inhibitory promiscuity - 0.9461 94.61%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5488 54.88%
Eye corrosion - 0.9889 98.89%
Eye irritation - 0.8977 89.77%
Skin irritation + 0.5679 56.79%
Skin corrosion - 0.9381 93.81%
Ames mutagenesis - 0.6664 66.64%
Human Ether-a-go-go-Related Gene inhibition + 0.7883 78.83%
Micronuclear - 0.8800 88.00%
Hepatotoxicity - 0.6195 61.95%
skin sensitisation - 0.9109 91.09%
Respiratory toxicity + 0.7667 76.67%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity - 0.5915 59.15%
Acute Oral Toxicity (c) III 0.4393 43.93%
Estrogen receptor binding + 0.7529 75.29%
Androgen receptor binding + 0.7623 76.23%
Thyroid receptor binding + 0.6802 68.02%
Glucocorticoid receptor binding + 0.7992 79.92%
Aromatase binding + 0.6648 66.48%
PPAR gamma + 0.8317 83.17%
Honey bee toxicity - 0.5761 57.61%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity + 0.9699 96.99%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL226 P30542 Adenosine A1 receptor 99.12% 95.93%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.77% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.21% 96.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 95.90% 86.33%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 95.06% 95.89%
CHEMBL1806 P11388 DNA topoisomerase II alpha 95.05% 89.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 94.76% 100.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.57% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.34% 97.09%
CHEMBL5255 O00206 Toll-like receptor 4 90.68% 92.50%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 90.06% 92.88%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.28% 95.56%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 88.57% 94.00%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 88.44% 96.00%
CHEMBL221 P23219 Cyclooxygenase-1 88.19% 90.17%
CHEMBL253 P34972 Cannabinoid CB2 receptor 87.28% 97.25%
CHEMBL340 P08684 Cytochrome P450 3A4 87.15% 91.19%
CHEMBL241 Q14432 Phosphodiesterase 3A 85.66% 92.94%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 85.57% 91.24%
CHEMBL2243 O00519 Anandamide amidohydrolase 85.53% 97.53%
CHEMBL3401 O75469 Pregnane X receptor 85.51% 94.73%
CHEMBL2581 P07339 Cathepsin D 85.32% 98.95%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 84.67% 95.50%
CHEMBL1871 P10275 Androgen Receptor 83.41% 96.43%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 82.83% 94.33%
CHEMBL2179 P04062 Beta-glucocerebrosidase 82.79% 85.31%
CHEMBL5028 O14672 ADAM10 82.24% 97.50%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 81.40% 96.90%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.36% 99.23%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Helleborus orientalis

Cross-Links

Top
PubChem 102245388
LOTUS LTS0228162
wikiData Q105007369